Platinol
information and resources from the National Cancer Institute
cisplatin
as a single agent for patients with transitional cell bladder cancer which is no longer amenable to local treatments such as surgery and/or radiotherapy.
Bristol-Myers Squibb Apr 22 1993
cisplatin
Metastatic ovarian tumors - in established combination therapy with other approved chemotherapeutic agents: Ovarian-in established combination therapy with other approved chemotherapeutic agents in patients with metastatic ovarian tumors who have already received appropriate surgical and/or radiotherapeutic procedures. An established combination consists of Platinol and Adriamycin. Platinol, as a single agent, is indicated as secondary therapy in patients with metastatic ovarian tumors refractory to standard chemotherapy who have not previously received Platinol therapy.
Bristol-Myers Squibb Dec 19 1978
cisplatin
Metastatic testicular-in established combination therapy with other approved chemotherapeutic agents in patients with metastatic testicular tumors whoc have already received appropriate surgical and/or radiotherapeutic procedures. An established combination therapy consists of Platinol, Blenoxane and Velbam.
Bristol-Myers Squibb Dec 19 1978
|
|
|
|
news articles
Gemzar®/Platinol® Superior to VePesid®/Platinol® in Non-Small ... Mar 29, 2006
Cancer Consultants (press release), ...to an article recently published in Lung Cancer, the chemotherapy combination consisting of Gemzar® (gemcitabine) plus Platinol® (cisplatin) improves ...
Tomudex® Plus Platinol® and Platinol Alone Reduce Dyspnea in ... Mar 22, 2006
Cancer Consultants (press release), EORTC) Lung Cancer Group and the National Cancer Institute of Canada have reported that the combination of Tomudex (raltitrexed) and Platinol® (cisplatin) or ...
Taxotere®/Platinol®/Herceptin® Effective in Locally Advanced ... Mar 22, 2006
Cancer Consultants (press release), ...an early online article published in the Journal of Clinical Oncology, the treatment regimen consisting of Taxotere® (docetaxel), Platinol® (cisplatin) and ...
Tomudex® Plus Eloxatin® Effective in Gemzar®-Resistant ... Mar 24, 2006
Cancer Consultants (press release), Platinum compounds such a Platinol® (cisplatin) and Eloxatin has been combined with Gemzar for the treatment of pancreatic cancer. ...
Alimta® and Paraplatin® Effective and Well-Tolerated in ... Mar 22, 2006
Cancer Consultants (press release), It is indicated for treatment of mesothelioma in combination with the chemotherapy agent Platinol® (cisplatin) among patients who are not eligible for surgery ...
Taxotere® Approved for Advanced Gastric Cancer Mar 24, 2006
Cancer Consultants (press release), The indication includes the combination of Taxotere with 5-fluorouracil and cisplatin (Platinol®) in patients with advanced gastric cancer who have not ...
Adjuvant High-Dose Chemotherapy Improves Outcomes of HER2/neu ... Mar 7, 2006
Cancer Consultants (press release), ...with high-risk localized breast cancer receiving high-dose chemotherapy with Cytoxan® (cyclophosphamide), Thiplex® (thiotepa), and Platinol® following FEC (5 ...
Concurrent Radiation Therapy and Chemotherapy for Small Cell Lung ... Mar 16, 2006
Cancer Consultants (press release), Combination chemotherapy treatment with Vepesid and Platinol® (cisplatin) results in complete remission (CR) in 40-60% of patients. ...
Chemotherapy and Radiation Therapy May Replace Surgery in Early ... Mar 3, 2006
Cancer Consultants (press release), Patients had the earliest stages of esophageal cancer and were treated with the chemotherapy agents Platinol® (cisplatin) and 5-fluorouracil, as well as ...
Chemotherapy plus Radiation Therapy Superior to Aggressive ... Mar 7, 2006
Cancer Consultants (press release), This trial included 163 patients who were treated with either chemotherapy, consisting of Platinol® (cisplatin) and 5-flurouracil (5-FU) plus standard ...
Erbitux® Plus Chemotherapy and Radiation Therapy Promising in ... Mar 2, 2006
Cancer Consultants (press release), ...recently conducted a clinical trial to evaluate the treatment regimen consisting of Erbitux, radiation therapy, and the chemotherapy agent Platinol® (cisplatin ...
Chemotherapy Lengthens Survival in Advanced Endometrial Carcinoma Dec 6, 2005
MedPage Today, 6 - For women with advanced endometrial carcinoma, Adriamycin (doxorubicin) and Platinol (cisplatin) improves survival more than whole-abdominal radiation ...
Induction Chemotherapy and Concomitant Chemoradiotherapy Promising ... Dec 6, 2005
Cancer Consultants (press release), ...reported a 3-year survival rate of 45% in patients with stage III NSCLC treated with induction Gemzar® (gemcitabine) and Platinol® (cisplatin) followed by ...
Addition of Taxol® to Chemotherapy Combination Improves Survival ... Nov 29, 2005
Cancer Consultants (press release), ...to a recent article published in the Journal of Clinical Oncology, the addition of the chemotherapy agent Taxol® (paclitaxel) to Platinol® (cisplatin) and 5 ...
|
|
